Supplementary Data from A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo
Le résumé fourni par la source
Supplementary methods Supplementary Text: Wolinella succinogenes as a low L-glutaminase L-asparaginase Supplementary Figures: • Fig. S1. In vivo imaging showing that the L-glutaminase-diminished ErA-63Q and ErA-DM variants eliminate T-ALL LOUCY cells as effectively as the high L-glutaminase ErA-WT. • Fig. S2: In vivo imaging showing that the low L-glutaminase ErA-DM variant eliminates B-ALL SUP-B15 cells as effectively as the high L-glutaminase ErA-WT. • Fig. S3. In vivo imaging showing that the ultra-low L-glutaminase ErA-TM variant eliminates T-ALL LOUCY cells as effectively as the high L-glutaminase ErA-WT. • Fig. S4. In vitro sensitivity of two human ALL cell lines to L-asparaginases. • Fig. S5: Calibration between the in vivo imaging flux intensity and the measured %huCD45+ levels in peripheral blood (PB). • Fig. S6. In vivo imaging with signal-to-color range adjusted. • Fig. S7. Correlation between L-glutaminase activity and the reduction in mice activity. • Fig. S8. Correlation between L-glutaminase activity of the ErA variants and mice weight loss. • Fig. S9. ASNS qPCR data for the LOUCY cell line and 5 ALL patient samples. Data. Biostatistics on BLI and weight data.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- Supplementary Data from A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias <i>In Vivo</i>
- Date Crossref
- 31/03/2023
- Éditeur
- American Association for Cancer Research (AACR)
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.